Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $161.8 million.

  • Bioventus' Total Current Liabilities fell 2351.86% to $161.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $161.8 million, marking a year-over-year decrease of 2351.86%. This contributed to the annual value of $210.4 million for FY2024, which is 1988.69% up from last year.
  • Per Bioventus' latest filing, its Total Current Liabilities stood at $161.8 million for Q3 2025, which was down 2351.86% from $185.7 million recorded in Q2 2025.
  • In the past 5 years, Bioventus' Total Current Liabilities ranged from a high of $304.0 million in Q4 2022 and a low of $149.0 million during Q2 2021
  • Its 5-year average for Total Current Liabilities is $193.3 million, with a median of $179.1 million in 2023.
  • As far as peak fluctuations go, Bioventus' Total Current Liabilities skyrocketed by 7944.25% in 2022, and later tumbled by 4422.4% in 2023.
  • Bioventus' Total Current Liabilities (Quarter) stood at $180.9 million in 2021, then skyrocketed by 68.1% to $304.0 million in 2022, then plummeted by 42.27% to $175.5 million in 2023, then increased by 19.89% to $210.4 million in 2024, then decreased by 23.12% to $161.8 million in 2025.
  • Its Total Current Liabilities was $161.8 million in Q3 2025, compared to $185.7 million in Q2 2025 and $174.8 million in Q1 2025.